Skip to main content
. 2021 Oct 19;12:692079. doi: 10.3389/fimmu.2021.692079

Figure 5.

Figure 5

Patients from TCGA cohort with high and low Ti-lncRNA scores were ranked by clinicopathological factors, genetic mutations, the hypoxia, CAF, and TAM scores, PDCD1 and CTLA4 expressions, and the expanded IGS score. *p < 0.05, **p < 0.01, ***p < 0.001. lncRNA, long non-coding RNA; Ti-lncRNA, tumor-infiltrating immune-related lncRNA; TCGA, The Cancer Genome Atlas; CAF, cancer-associated fibroblast; TAM, tumor-associated macrophage; IGS, immune gene signature.